Albany Molecular Research, Inc. (AMRI) Announces First Quarter 2014 Results

Published: May 06, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALBANY, New York, May 06, 2014 (PR Newswire Europe via COMTEX) -- -- Contract Revenue Growth of 10% to $51.0 Million and Adjusted Diluted EPS of $0.16

-- Company Increases 2014 Adjusted EPS Guidance to $0.78 - $0.84 to Reflect Addition of Cedarburg Pharmaceuticals and Strengthening Contract Business

Help employers find you! Check out all the jobs and post your resume.

Back to news